Within the past 2 years, interest in investigator-initiated clinical trials has increased greatly. The additional proof of practice and clinical application data that these types of trials provide have allowed for the transition of many newly approved therapies to standard practice.

While research offices are doing their best to support these endeavors, the additional administrative responsibilities involved are often unfamiliar, as they are normally taken on by industry sponsors and outside governmental agencies, including the new “final rule” requirements.

Join Velos and PFS Clinical for an informative, no-cost webinar on investigator-initiated trials and the "final rule" requirements on Thursday, September 14 at 12:00 PM CST. Besides getting tips and models for meeting requirements, learn how technology can help you develop protocols, observe compliance, and simplify submissions to clinicaltrials.gov.

Register here: anymeeting.com/PIID=ED52DE86844C38 

Join PFS Clinical For a Webinar on "Investigator Initiated Trials - Administrative Considerations for Successful Study Start-Up and Close Out". 

The main points covered in this webinar will be: 

1. How to articulate study status (interventional vs observational) during protocol development for correct billing and budgeting
2. Discuss strategies for partnering with industry funders in order to financially support IIT endeavors
3. Discuss recent changes to the Final Rule offering suggestions on how to implement compliant change

This webinar will be hosted by HCCA. Register here. 

One of the most important aspects of a clinical trial is a budget that adequately meets the financial needs of your institution; however, in the context of billing compliance, the process of building and negotiating a study budget can become complicated.

In this upcoming webinar, seasoned PFS Clinical staff Amanda Miller and Jill Surfus will review the basics of clinical trial budgeting, provide language tips to prevent potential compliance issues, and discuss how to incorporate a coverage analysis into the budgeting process. 

We hope you’ll join us for this complimentary webinar!

Billing compliance is a crucial aspect of any organization that conducts clinical trials. Nonetheless, understanding and applying reimbursement guidelines is one of the most challenging aspects of research. In addition to providing quality patient care, institutions have the added task of understanding and complying with all federal and state guidelines related to clinical research billing practices. These tasks are not only time consuming, but can lead to errors that are costly and could impact your organization’s Medicare standing. Join Senior Clinical Research Analysts Liz Christianson and Nicole Bruecker for a complimentary webinar during which you will learn:

• The basics of billing compliance and why it is necessary
• How to create a coverage analysis to achieve and document billing compliance
• The PI’s role in the billing compliance process

We hope you join us for this informative, no-cost presentation!

Within the past 2 years, interest in investigator-initiated clinical trials has increased greatly. The additional proof of practice and clinical application data that these types of trials provide have allowed for the transition of many newly approved therapies to standard practice. 

While research offices are doing their best to support these endeavors, the additional administrative responsibilities involved are often unfamiliar, as they are normally taken on by industry sponsors and outside governmental agencies. Consequently, mistakes made during the initial development and start-up stages of these trials are causing institutions significant financial and compliance-related ramifications. 

Join Clinical Research Analyst Liz Christianson as she discusses how to overcome these start-up struggles and oversights of investigator-initiated trials.

Register Here

Learn more about the conference here.